Cargando…

COVID-19 mRNA Vaccine Safety Among Children Aged 6 Months–5 Years — United States, June 18, 2022–August 21, 2022

Detalles Bibliográficos
Autores principales:	Hause, Anne M., Marquez, Paige, Zhang, Bicheng, Myers, Tanya R., Gee, Julianne, Su, John R., Parker, Casey, Thompson, Deborah, Panchanathan, Sarada S., Shimabukuro, Tom T., Shay, David K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2022
Materias:	Full Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472776/ https://www.ncbi.nlm.nih.gov/pubmed/36048728 http://dx.doi.org/10.15585/mmwr.mm7135a3

Ejemplares similares

Safety Monitoring of mRNA COVID-19 Vaccine Third Doses Among Children Aged 6 Months–5 Years — United States, June 17, 2022–May 7, 2023
por: Hause, Anne M., et al.
Publicado: (2023)

Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Persons Aged ≥12 Years — United States, August 31–October 23, 2022
por: Hause, Anne M., et al.
Publicado: (2022)

Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Children Aged 5–11 Years — United States, October 12–January 1, 2023
por: Hause, Anne M., et al.
Publicado: (2023)

Safety Monitoring of COVID-19 mRNA Vaccine Second Booster Doses Among Adults Aged ≥50 Years — United States, March 29, 2022–July 10, 2022
por: Hause, Anne M., et al.
Publicado: (2022)

Reactogenicity of Simultaneous COVID-19 mRNA Booster and Influenza Vaccination in the US
por: Hause, Anne M., et al.
Publicado: (2022)

Safety Monitoring of COVID-19 mRNA Vaccine First Booster Doses Among Persons Aged ≥12 Years with Presumed Immunocompromise Status — United States, January 12, 2022–March 28, 2022
por: Hause, Anne M., et al.
Publicado: (2022)

Safety Monitoring of an Additional Dose of COVID-19 Vaccine — United States, August 12–September 19, 2021
por: Hause, Anne M., et al.
Publicado: (2021)

Safety Monitoring of Pfizer-BioNTech COVID-19 Vaccine Booster Doses Among Children Aged 5–11 Years — United States, May 17–July 31, 2022
por: Hause, Anne M., et al.
Publicado: (2022)

Safety Monitoring of COVID-19 Vaccine Booster Doses Among Persons Aged 12–17 Years — United States, December 9, 2021–February 20, 2022
por: Hause, Anne M., et al.
Publicado: (2022)

Safety Monitoring of COVID-19 Vaccine Booster Doses Among Adults — United States, September 22, 2021–February 6, 2022
por: Hause, Anne M., et al.
Publicado: (2022)

Reactogenicity within 2 weeks after mRNA COVID-19 vaccines: Findings from the CDC v-safe surveillance system
por: Chapin-Bardales, Johanna, et al.
Publicado: (2021)

Menstrual irregularities and vaginal bleeding after COVID-19 vaccination reported to v-safe active surveillance, USA in December, 2020–January, 2022: an observational cohort study
por: Wong, Karen K, et al.
Publicado: (2022)

COVID-19 Vaccine Safety in Children Aged 5–11 Years — United States, November 3–December 19, 2021
por: Hause, Anne M., et al.
Publicado: (2021)

Editorial: EAIT 21 − 7 (August 2022)
por: Tatnall, Arthur
Publicado: (2022)

Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safe
por: Rosenblum, Hannah G, et al.
Publicado: (2022)

Safety Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine — United States, March–April 2021
por: Shay, David K., et al.
Publicado: (2021)

Association between history of SARS-CoV-2 infection and severe systemic adverse events after mRNA COVID-19 vaccination among U.S. adults
por: Tompkins, Lindsay K., et al.
Publicado: (2022)

Safety Monitoring of JYNNEOS Vaccine During the 2022 Mpox Outbreak — United States, May 22–October 21, 2022
por: Duffy, Jonathan, et al.
Publicado: (2022)

Editors’ Choice: August 2022
por: Tovey, David, et al.
Publicado: (2022)

Safety of co-administration of mRNA COVID-19 and seasonal inactivated influenza vaccines in the vaccine adverse event reporting system (VAERS) during July 1, 2021–June 30, 2022
por: Moro, Pedro L., et al.
Publicado: (2023)

COVID-19 Vaccine Safety in Adolescents Aged 12–17 Years — United States, December 14, 2020–July 16, 2021
por: Hause, Anne M., et al.
Publicado: (2021)

Anxiety-Related Adverse Event Clusters After Janssen COVID-19 Vaccination — Five U.S. Mass Vaccination Sites, April 2021
por: Hause, Anne M., et al.
Publicado: (2021)

Editors’ message June 2022
por: Wong, Nathan D., et al.
Publicado: (2022)

Epilepsia Open—June 2022—Announcements
Publicado: (2022)

PRAC meeting highlights June 2022
Publicado: (2022)

Jordi Mancebo, in memoriam (August 06 2022)
por: Brochard, Laurent, et al.
Publicado: (2022)

Campbell title registrations to date—August 2022
Publicado: (2022)

Human vaccines & immunotherapeutics: News August 2022
por: Ellis, Ronald, et al.
Publicado: (2022)

The v-safe after vaccination health checker: Active vaccine safety monitoring during CDC’s COVID-19 pandemic response
por: Myers, Tanya R., et al.
Publicado: (2023)

In this issue: Volume 113, Issue 8, August 2022
Publicado: (2022)

Top EFT summary plots June 2022
por: The ATLAS collaboration
Publicado: (2022)

Avian influenza overview June – September 2022
por: Adlhoch, Cornelia, et al.
Publicado: (2022)

Avian influenza overview March – June 2022
por: Adlhoch, Cornelia, et al.
Publicado: (2022)

Human Vaccines & immunotherapeutics: News, June 2022
Publicado: (2022)

Nosocomial outbreak by NDM-1-producing Klebsiella pneumoniae highly resistant to cefiderocol, Florence, Italy, August 2021 to June 2022
por: Coppi, Marco, et al.
Publicado: (2022)

CAEP/ACMU 2022 Scientific Abstracts: May 29th – June 1st, 2022
Publicado: (2022)

Public Health Response to a Case of Paralytic Poliomyelitis in an Unvaccinated Person and Detection of Poliovirus in Wastewater — New York, June–August 2022
por: Link-Gelles, Ruth, et al.
Publicado: (2022)

ATLAS Collaboration Member Nationalities Map (June 2022)
por: Anthony, Katarina
Publicado: (2018)

Top quark mass summary plots June 2022
por: The ATLAS collaboration
Publicado: (2022)

Top Quarks + X Summary Plots June 2022
por: The ATLAS collaboration
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ojs0hgsojv7c15evvdiq95q528